Symposium

Biopharma Solutions Technical Symposium

September 30, 2025​ | Cambridge, MA, USA


Overview

Join us for an engaging symposium focusing on innovative biopharma solutions. This event is designed for professionals in the biopharmaceutical industry to explore advancements in cell culture technology and enhance their understanding of bioprocess optimization.

Why Attend?

This symposium offers a unique opportunity to learn from academic and industry experts, engage in insightful discussions, and connect with peers who are shaping the future of biopharma.



Key learnings for participants

  • Innovative Approaches: Gain insights into the latest advancements in cell culture and media development that drive efficiency in biopharmaceutical production.
  • Expert Presentations: Hear from leading experts on topics such as enhancing mAb production and the role of peptides in bioprocess optimization.
  • New Product Launches: Discover our latest product developments and innovations that are set to transform the biopharmaceutical landscape.
  • Networking Opportunities: Connect with industry leaders and fellow professionals in a collaborative environment, fostering meaningful exchanges and potential partnerships.
  • Interactive Discussions: Participate in engaging discussions that tackle current challenges and explore future directions in biopharma solutions.
  • Lab Tour: Experience a guided tour of our laboratory facilities, providing firsthand insights into our innovative processes and technologies.
  • Academic Insights: Engage with two distinguished academic guest speakers who will share their expertise and perspectives on current trends in biopharma.






Note: Please fill in your details and click 'Submit' to register for the workshop. Once we have received your registration, we will send you a status notification as soon as possible. Due to the high demand for our workshops, we sometimes need to reject registrations or put you on a waiting list. Workshop materials will be available for download at the end of the workshop. Any photographs taken during the event are the property of Evonik and may be used for promotional purposes.



Details
Participation fee: Free of charge 
Language: English



Agenda
The symposium will start at 08:30 a.m. on Tuesday, September 30, 2025, and finish at 04:15 p.m. on the same day. To see the detailed workshop program please click here.



Venue
The symposium will take place at:
238 Main Street
Cambridge, MA 02142 (located at Kendall/M.I.T. MBTA stop)
USA




Fill out the form to register for the symposium:

Agenda

08:30 a.m. | Registration & Breakfast​​

09:00 a.m. | Intro to Evonik Cell Culture Solutions
Jessica Young
Associate Director, Business Development
Evonik Health Care

09:30 a.m. | Development and Characterization of Media Supplements to Improve Cell Culture Performance
Jianfa Ou
Principal Scientist
Evonik Health Creavis

10:00 a.m. | Unleash the power of high-throughput CE to drive antibody discovery with LabChip GXII Touch platform
Jerry Peng
Sr Product Specialist
Revvity

10:45 a.m. | Coffee Break & Networking​

11:00 a.m. | Efficiency Enhancement in mAb Production: Streamlining Bioprocesses with Peptides to Boost CHO Cell Culture Performance
Zach Demorest
Director of Biopharma Solutions
Evonik Health Care

11:30 a.m. | Guest Speaker
Seonkyu Yoon
Department of Chemical Engineering
University of Massachusetts Lowell

12:15 p.m.|  Lunch & Networking

1:15 p.m. | Animal Free and Sustainable Solutions - PhytoChol® BioPharma and New Products
Zach Demorest
Director of Biopharma Solutions
Evonik Health Care

Yawen Tang
Senior Scientist
Evonik Health Creavis

1:45 p.m. | Building Fruitful Collaborations between Industry and Academia Through the AMBIC Initiative
Michael Betenbaugh
Department of Chemical and Biomolecular Engineering
John’s Hopkins University

2:30 p.m.| Coffee Break & Networking​

2:45 p.m. | Guest Speaker
Eric Yong
Worcester Polytechnic Institute
Chemical Engineering

3:30 p.m. | Cambridge Innovation Satellite Activities - Research Capabilities and Collaboration
Andrea Engel
Head, Cell and Delivery Systems
Evonik Health Creavis

3:45 p.m.| Lab Tours and Networking Hour

4:45 p.m.| End of workshop





Disclaimer

Notice for business transactions
We assume that you are not currently or foreseeably involved in a business decision in favour of or in direct connection with the Evonik Group or, if this is the case, the decision will not be influenced by this invitation. Therefore, we do not see any concerns on our part regarding your participation. However, we would like to ask you to ensure that you are allowed to accept the invitation in accordance with the regulations that apply to you.

Note for public officials
We assume that you are not or have not been involved in any official act in favour of or in connection with the Evonik Group, either now or in the foreseeable future or in the past and therefore your participation in the event is not subject to any concerns. In addition, we ask you to ensure that your superior approves your participation or you may also accept the invitation in accordance with the rules applicable to you. By registering or participating, you confirm to us that the acceptance of this invitation is permitted according to your internal rules and that you have obtained all necessary approvals. If this is not the case, we ask you for a corresponding note.

Tax notices
Any tax liability resulting from this event will be borne by Evonik Industries AG through a flat-rate tax levy pursuant to Section 37b of the German Income Tax Act (EStG). If you are not taxable in Germany, please clarify whether you must report the invitation to your employer for taxation or whether taxation must be made via your income tax return.




QUESTIONS? 

Griffin Brownback
Sales & Marketing Analyst | North America
+1 732 981 5298

Cléa Michel

Cléa Michel is product manager for Cell Culture Ingredients at Evonik Health Care. She provides biopharma companies and media manufacturers with the finest specialty ingredients to increase cell culture performance. Cléa has a background in biochemistry and biotechnology engineering and holds a master’s degree from the National Institute of Applied Sciences in Lyon, France. She has held various positions in marketing, project management and business development and is passionate about innovative solutions that enable the successful development of life-saving biopharmaceuticals.
Dr. Stephan Brinkmann

Stephan Brinkmann works as project manager and head of Evonik's Biopharma Applications group at Evonik R&D for the Health Care business line. He is responsible for biopharma innovation projects as well as application tests of Evonik's cell culture ingredients (i.e., cQrex® peptides). Stephan studied molecular biotechnology at Bielefeld University in Germany, where he specialized in biopharma upstream and downstream process development. Before joining Evonik, Stephan worked in Switzerland on industrial mammalian cell line development for the production of therapeutic biologics. Stephan obtained his Ph.D. in a public private partnership with Sanofi and later Evotec at Fraunhofer IME in Giessen with a focus on the discovery of natural products, especially peptides.

Headline H3 - Boxes and Form

Lorem ipsum dolor sit amet, consetetur sadipscing elitr, sed diam nonumy eirmod tempor invidunt ut labore et dolore magna aliquyam erat, sed diam voluptua. At vero eos et accusam et justo duo dolores et ea rebum. Stet clita kasd gubergren, no sea takimata sanctus est Lorem ipsum dolor sit amet. Lorem ipsum dolor sit amet, consetetur sadipscing elitr, sed diam nonumy eirmod tempor invidunt ut labore et dolore magna aliquyam erat, sed diam voluptua. At vero eos et accusam et justo duo dolores et ea rebum. Stet clita kasd gubergren, no sea takimata sanctus est Lorem ipsum dolor sit amet.

Register

Headline H3 - Boxes and Form

Lorem ipsum dolor sit amet, consetetur sadipscing elitr, sed diam nonumy eirmod tempor invidunt ut labore et dolore magna aliquyam erat, sed diam voluptua. At vero eos et accusam et justo duo dolores et ea rebum. Stet clita kasd gubergren, no sea takimata sanctus est Lorem ipsum dolor sit amet. Lorem ipsum dolor sit amet, consetetur sadipscing elitr, sed diam nonumy eirmod tempor invidunt ut labore et dolore magna aliquyam erat, sed diam voluptua. At vero eos et accusam et justo duo dolores et ea rebum. Stet clita kasd gubergren, no sea takimata sanctus est Lorem ipsum dolor sit amet.

Register